Key result
Drug-eluting stent implantation and warfarin plus P2Y12 inhibitor therapy were feasible for treating recurrent myocardial infarction caused by progressive coronary artery ectasia.
Drug-eluting stent implantation and antithrombotic therapy with warfarin plus a P2Y12 inhibitor are feasible for managing recurrent myocardial infarction caused by progressive coronary artery ectasia.
Answers are grounded in this paper and cite their sources.
Supports DES plus warfarin-P2Y12 in progressive CAE-related recurrent MI; hypothesis-generating and requires prospective validation.
We present a case of recurrent myocardial infarction with coronary artery ectasia that had progressive dilation. Both implanting drug-eluting stent and antithrombotic therapy with warfarin plus P2Y12 inhibitor were feasible. The careful follow-up including morphologic evaluation may be needed for this specific lesion. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Imaoka et al. (2023) studied this question. Drug-eluting stent implantation and warfarin plus P2Y12 inhibitor therapy were feasible for treating recurrent myocardial infarction caused by progressive coronary artery ectasia.
Synapse has enriched 10 related papers. Consider them for comparative context: